| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
(Circulation. 2000;102:96.)
© 2000 American Heart Association, Inc.
Basic Science Reports |
From the Cardiology Unit, Department of Medicine, and Department of Neurobiology and Anatomy, University of Rochester Medical Center, Rochester, NY.
Correspondence to Chang-seng Liang, MD, PhD, Cardiology Unit, Box 679, University of Rochester Medical Center, 601 Elmwood Ave, Box 679, Rochester, NY 14642-8679. E-mail chang-seng_liang{at}urmc.rochester.edu
BackgroundChronic excessive norepinephrine (NE) causes cardiac sympathetic nerve terminal abnormalities, myocardial ß-adrenergic receptor downregulation, and ß-adrenergic subsensitivity. The present study was carried out to determine whether these changes could be prevented by antioxidants.
Methods and ResultsFerrets were administered either NE (1.33
mg/d) or vehicle by use of subcutaneous pellets for 4 weeks. Animals
were simultaneously assigned to receive either antioxidant
vitamins (ß-carotene, ascorbic acid, and
-tocopherol)
or placebo pellets. NE increased plasma NE 4- to 5-fold but had no
effect on heart rate, heart weight, arterial pressure, or
left ventricular systolic function. However,
myocardial NE uptake activity and NE uptake-1 site density were
reduced, as well as cardiac neuronal NE, tyrosine hydroxylase, and
neuropeptide Y. In addition, there was a decrease in myocardial
ß-adrenergic receptor density with a selective decrease of the
ß1-receptor subtype, reduction of the high-affinity site
for isoproterenol, decreased basal adenylyl cyclase activity, and the
adenylyl cyclase responses to isoproterenol, Gpp(NH)p, and forskolin.
All of these changes were prevented by antioxidant vitamins. The
effects of NE on myocardial ß-adrenergic receptor density, NE
uptake-1 carrier site density, and neuronal NE were also prevented by
superoxide dismutase or Trolox C.
ConclusionsThe toxic effects of NE on the sympathetic nerve terminals are mediated via the formation of NE-derived oxygen free radicals. Preservation of the neuronal NE reuptake mechanism is functionally important, because the antioxidants also prevented myocardial ß-adrenergic receptor downregulation and postreceptor abnormalities. Thus, antioxidant therapy may be beneficial in heart failure, in which cardiac NE release is increased.
Key Words: norepinephrine antioxidants receptors, adrenergic, beta heart failure
This article has been cited by other articles:
![]() |
R. Sethi, A. Adameova, K. S. Dhalla, M. Khan, V. Elimban, and N. S. Dhalla Modification of Epinephrine-induced Arrhythmias by N-Acetyl-L-Cysteine and Vitamin E Journal of Cardiovascular Pharmacology and Therapeutics, June 1, 2009; 14(2): 134 - 142. [Abstract] [PDF] |
||||
![]() |
C.-s. Liang, W. Mao, C. Iwai, S. Fukuoka, and S. Y. Stevens Cardiac sympathetic neuroprotective effect of desipramine in tachycardia-induced cardiomyopathy Am J Physiol Heart Circ Physiol, March 1, 2006; 290(3): H995 - H1003. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Cohen-Solal, F. Rouzet, A. Berdeaux, D. Le Guludec, E. Abergel, A. Syrota, and P. Merlet Effects of Carvedilol on Myocardial Sympathetic Innervation in Patients with Chronic Heart Failure J. Nucl. Med., November 1, 2005; 46(11): 1796 - 1803. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Mao, C. Iwai, F. Qin, and C.-s. Liang Norepinephrine induces endoplasmic reticulum stress and downregulation of norepinephrine transporter density in PC12 cells via oxidative stress Am J Physiol Heart Circ Physiol, May 1, 2005; 288(5): H2381 - H2389. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Kawai, F. Qin, J. Shite, W. Mao, S. Fukuoka, and C.-s. Liang Importance of antioxidant and antiapoptotic effects of {beta}-receptor blockers in heart failure therapy Am J Physiol Heart Circ Physiol, September 1, 2004; 287(3): H1003 - H1012. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Mao, F. Qin, C. Iwai, R. Vulapalli, P. C. Keng, and C.-s. Liang Extracellular norepinephrine reduces neuronal uptake of norepinephrine by oxidative stress in PC12 cells Am J Physiol Heart Circ Physiol, July 1, 2004; 287(1): H29 - H39. [Abstract] [Full Text] [PDF] |
||||
![]() |
B.-i. Kato, T. Nozawa, N. Igarashi, M. Nonomura, N. Fujii, A. Igawa, H. Asanoi, Y. Yamada, M. Inoue, and H. Inoue Discrepant Recovery Course of Sympathetic Neuronal Function and {beta}-Adrenoceptors in Rat Hearts After Reperfusion Following Transient Ischemia J. Nucl. Med., June 1, 2004; 45(6): 1074 - 1080. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Mak and G. E. Newton Redox modulation of the inotropic response to dobutamine is impaired in patients with heart failure Am J Physiol Heart Circ Physiol, February 1, 2004; 286(2): H789 - H795. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. M. Canty Jr and J. A. Fallavollita Sympathetic Nerves and Myocyte Necrosis: More Than Meets the Eye Circ. Res., October 31, 2003; 93(9): 796 - 798. [Full Text] [PDF] |
||||
![]() |
F. Moritz, C. Monteil, M. Isabelle, F. Bauer, S. Renet, P. Mulder, V. Richard, and C. Thuillez Role of reactive oxygen species in cocaine-induced cardiac dysfunction Cardiovasc Res, October 1, 2003; 59(4): 834 - 843. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Qin, J. Shite, and C.-s. Liang Antioxidants attenuate myocyte apoptosis and improve cardiac function in CHF: association with changes in MAPK pathways Am J Physiol Heart Circ Physiol, July 11, 2003; 285(2): H822 - H832. [Abstract] [Full Text] [PDF] |
||||
![]() |
C.-s. Liang, A. Yatani, Y. Himura, M. Kashiki, and S. Y. Stevens Desipramine attenuates loss of cardiac sympathetic neurotransmitters produced by congestive heart failure and NE infusion Am J Physiol Heart Circ Physiol, May 1, 2003; 284(5): H1729 - H1736. [Abstract] [Full Text] [PDF] |
||||
![]() |
C.-S. Liang, Y. Himura, M. Kashiki, and S. Y. Stevens Differential pre- and postsynaptic effects of desipramine on cardiac sympathetic nerve terminals in RHF Am J Physiol Heart Circ Physiol, November 1, 2002; 283(5): H1863 - H1872. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Merlet, L. Hittinger, J. L. Dubois-Rande, and A. Castaigne Myocardial Adrenergic Dysinnervation in Dilated Cardiomyopathy: Cornerstone or Epiphenomenon? J. Nucl. Med., April 1, 2002; 43(4): 536 - 539. [Full Text] [PDF] |
||||
![]() |
Y. T. Sia, T. G. Parker, P. Liu, J. N. Tsoporis, A. Adam, and J. L. Rouleau Improved post-myocardial infarction survival with probucol in rats: Effects on left ventricular function, morphology, cardiac oxidative stress and cytokine expression J. Am. Coll. Cardiol., January 2, 2002; 39(1): 148 - 156. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Zaugg, M. C. Schaub, T. Pasch, and D. R. Spahn Modulation of {beta}-adrenergic receptor subtype activities in perioperative medicine: mechanisms and sites of action Br. J. Anaesth., January 1, 2002; 88(1): 101 - 123. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Shite, F. Qin, W. Mao, H. Kawai, S. Y. Stevens, and C.-s. Liang Antioxidant vitamins attenuate oxidative stress and cardiac dysfunction in tachycardia-induced cardiomyopathy J. Am. Coll. Cardiol., November 15, 2001; 38(6): 1734 - 1740. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Qin, N. K. Rounds, W. Mao, K. Kawai, and C.-s. Liang Antioxidant vitamins prevent cardiomyocyte apoptosis produced by norepinephrine infusion in ferrets Cardiovasc Res, September 1, 2001; 51(4): 736 - 748. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Kawai, S. Y. Stevens, and C.-S. Liang Renin-angiotensin system inhibition on noradrenergic nerve terminal function in pacing-induced heart failure Am J Physiol Heart Circ Physiol, December 1, 2000; 279(6): H3012 - H3019. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Qin, R. S. Vulapalli, S. Y. Stevens, and C.-S. Liang Loss of cardiac sympathetic neurotransmitters in heart failure and NE infusion is associated with reduced NGF Am J Physiol Heart Circ Physiol, January 1, 2002; 282(1): H363 - H371. [Abstract] [Full Text] [PDF] |
||||
|
Circulation Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2000 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |